Women who exercise regularly have a significantly lower risk of an early death or fatal cardiovascular event than men who exercise regularly, even when women put in less effort, according to a National Institutes of Health-supported study.
FDA lifts partial hold on Arcellx’s Gilead-partnered blood cancer cell therapy as biotech aims for 2026 launch
Arcellx’s Gilead-partnered multiple myeloma cell therapy is in the clear, as the FDA has removed the partial clinical hold it placed on the CAR-T candidate
August 16, 2023